Media notice - The Annual International Generic Pharmaceutical Alliance
conference
Coming together for the first time in Canada, the world's key players in the generic pharmaceutical industry choose Montreal
An industry at the heart of Quebec's economic growth
This choice confirms that, contrary to the widely held myth that the generic pharmaceutical industry is developing only outside of
Another noteworthy fact attesting to a major change in the
The Canadian generic pharmaceutical industry allocates more than 15% of its revenues to research and development, or almost two times as much as brand-name pharmaceutical companies. In concrete terms, this represents investments of
About the Conference
This event, which will be held from
"This annual conference represents an ideal opportunity for obtaining the latest information on our industry's advances and breakthroughs at every level. It also allows us to identify the challenges we will face over the coming years and establish the foundations for future actions that will enable us to ensure our industry's continued development. It is a forum of choice for demonstrating the key role we must play, if we are to contribute to economic growth and help reduce the cost of the health care systems in
About the Canadian Generic Pharmaceutical Association
The Canadian Generic Pharmaceutical Association (CGPA) represents Canada's generic drug industry - a dynamic group of companies that specialize in the production of high quality, affordable generic drugs and fine chemicals and in conducting the clinical trials required for government approval of generic drugs. The industry plays an important role in controlling health-care costs in
For further information: For further information: Patricia Archambault, (514) 251-1044, Mobile: (514) 710-1044; Diane Jeannotte, (514) 284-2860 ext. 2, Mobile: (514) 772-8019
Share this article